MoneyWorks4Me

Jenburkt Pharmaceuticals board to consider Dividend

21 May 2014 Evaluate

Jenburkt Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on May 30, 2014, to consider and take on record the audited results for the financial year ended on March 31, 2014 and to recommend Dividend, if any.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..